NAD(P)H-quinone oxidoreductase 1 (NQO1)—a critical phase I detoxifying enzyme involved in the chemoresistance to 5-fluorouracil (5-FU), doxorubicin, or gemcitabine—is also overexpressed in CCA cells [58]. This evidence concerns the gene NQO1 and cholangiocarcinoma.